STACIA STAPLES: Open Payments
NPI 1851549422 · AUBURN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 20 payments from 8 companies in 2025. Trend: 2023 $872 · 2024 $580 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
| Novo Nordisk Inc | 3 | $50 |
| PFIZER INC. | 2 | $35 |
| Corcept Therapeutics | 2 | $32 |
| Lilly USA, LLC | 1 | $20 |
| Biogen, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, Wegovy, QULIPTA, NURTEC ODT, Korlym, ZEPBOUND, ZURZUVAE.
Industry payments across KY — which companies pay providers there.
